UnitedHealth reports another strong quarter

Henrietta Strickland
January 16, 2020

According to FactSet, analysts expect Dollars 3.78 per share. The company has a current ratio of 0.70, a quick ratio of 0.70 and a debt-to-equity ratio of 0.67. The firm owned 48,879 shares of the real estate investment trust's stock after selling 11,373 shares during the quarter. The stock has a market cap of $6.02 billion, a P/E ratio of 10.93, a P/E/G ratio of 2.35 and a beta of 0.72. The consensus estimates call for $3.78 in earnings per share (EPS) and $61.04 billion in revenue.

Several other large investors also recently bought and sold shares of QQQ. The company had revenue of $292.97 million for the quarter, compared to the consensus estimate of $290.51 million.

In morning trading Wednesday, UnitedHealth Group shares were up more than 2%.

UnitedHealth Group finished its strong 2019 with robust year-end earnings, including full year revenues of $242 billion and net earnings per share (EPS) that rose by 18%.

The company also recently declared a quarterly dividend, which was paid on Tuesday, December 17th. Shareholders of record on Tuesday, December 24th were paid a dividend of $0.4577 per share. This represents a $4.32 annualized dividend and a dividend yield of 1.45%. The ex-dividend date of this dividend is Friday, January 3rd.

Growing Medicare Advantage coverage and fat profits from UnitedHealth's Optum business, which strays beyond the company's health insurance core, contributed to better-than-expected earnings in the quarter.

BRX has been the topic of a number of recent research reports.

Credit Suisse has an Outperform rating with a $330 price target. Morgan Stanley reduced their price target on shares of Duke Energy from $96.00 to $95.00 and set an "equal weight" rating for the company in a research report on Monday, December 16th. They issued a "neutral" rating and a $90.00 target price on the stock. Finally, Mizuho reissued a buy rating and set a $300.00 price target (up previously from $270.00) on shares of UnitedHealth Group in a research report on Tuesday, November 26th. Finally, Goldman Sachs Group upgraded shares of Duke Energy from a "sell" rating to a "buy" rating and upped their price objective for the stock from $88.00 to $93.00 in a report on Wednesday, November 27th. Five investment analysts have rated the stock with a hold rating and nineteen have issued a buy rating to the company's stock. Duke Energy now has an average rating of "Hold" and a consensus price target of $95.17.

From a moat perspective, UnitedHealth appears advantaged in its diversified healthcare-related operations, including insurance, pharmacy benefit management, services, and analytics, and those advantages are reflected in its narrow moat rating. The shares were sold at an average price of $21.37, for a total value of $160,275.00. The disclosure for this sale can be found here. It operates through the following segments: Electric Utilities and Infrastructure, Gas Utilities and Infrastructure, and Commercial Renewables.

Minnetonka-based UnitedHealth Group runs UnitedHealthcare, which is the nation's largest health insurer, as well as Optum, a health services business that includes direct patient care, IT and health care consulting and management of pharmaceutical benefits.

Other reports by Click Lancashire

Discuss This Article